EMVision Medical Devices Ltd (ASX:EMV)
Australia · Delayed Price · Currency is AUD 1.750
-0.060 (-3.31%)
At close: Feb 5, 2026
EMVision Medical Devices Company Description
EMVision Medical Devices Ltd engages in the research, development, and commercialization of neurodiagnostic technology for stroke diagnosis and monitoring, and other medical imaging needs in Australia.
It offers non-invasive brain scanners, including emu Brain Scanner, a bedside device; and First Responder Brain Scanner, a device embedded in standard road and air ambulances to deliver pre-hospital stroke diagnosis and care to patients.
The company was incorporated in 2017 and is based in Macquarie Park, Australia.
EMVision Medical Devices Ltd
| Country | Australia |
| Founded | 2017 |
| Industry | Medical Devices |
| Sector | Healthcare |
| CEO | Scott Kirkland |
Contact Details
Address: 65 Epping Road Macquarie Park, NSW 2113 Australia | |
| Phone | 61 2 8667 5337 |
| Website | emvision.com.au |
Stock Details
| Ticker Symbol | EMV |
| Exchange | Australian Securities Exchange |
| Fiscal Year | July - June |
| Reporting Currency | AUD |
| ISIN Number | AU0000028375 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Scott Philip Kirkland | Co-founder, Chief Executive Officer, MD and Executive Director |
| Emma Waldon | Chief Financial Officer and Company Secretary |
| Forough Khandan | Chief Technology Officer |
| Dr. Stuart Crozier B.E., M.Sc., Ph.D. | Chief Scientific Officer |
| Robert Tiller | Head of Design |
| Dr. Konstanty Bialkowski | Head of Tech Development |
| Dr. Christian Wight | Head of Regulatory, Quality and Clinical Operations |